Serotonin reuptake inhibitors augmentation with cariprazine in patients with treatment-resistant obsessive-compulsive disorder: a retrospective observational study

被引：3
|
作者：
Martiadis, Vassilis [1 ]
Pessina, Enrico [2 ]
Martini, Azzurra [2 ]
Raffone, Fabiola [1 ]
Cattaneo, Carlo I. [3 ]
De Berardis, Domenico [4 ]
Pampaloni, Ilenia [5 ]
机构：
[1] ASL Napoli 1 Ctr, Dept Mental Hlth, Naples, Italy
[2] ASL CN2, Dept Mental Hlth, Bra, Italy
[3] ASL 12, Dept Mental Hlth, Biella, Italy
[4] ASL 4 Teramo, Dept Mental Hlth, Teramo, Italy
[5] South West London & St Georges Mental Hlth NHS Tru, Natl OCD BDD Serv, London, England
来源：
CNS SPECTRUMS | 2024年
关键词：
OCD; augmentation strategies; cariprazine; antipsychotic augmentation; refractory OCD; ANTIPSYCHOTIC AUGMENTATION; DOUBLE-BLIND;
D O I：
10.1017/S1092852924000348
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：296 / 299
页数：4
相关论文
共 50 条
  • [31] Lamotrigine Augmentation in Treatment-Resistant Pediatric Obsessive-Compulsive Disorder with a 16 Month Follow-up
    Naguy, Ahmed
    Alamiri, Bibi
    Al-Khadhari, Souleiman
    Francis, Konstantinos
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (08) : 769 - 772
  • [32] A systematic review of cognitive-behavioral therapy for pharmacotherapy treatment-resistant obsessive-compulsive disorder
    Sijercic, Iris
    Whitfield, Kristen M.
    Cassin, Stephanie E.
    Antony, Martin M.
    JOURNAL OF OBSESSIVE-COMPULSIVE AND RELATED DISORDERS, 2020, 26
  • [33] Off-label higher doses of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: Safety and tolerability
    Levy, Daniel Minkin
    Ben Arush, Oded
    Carmi, Lior
    Wetzler, Alzbeta Juven
    Zohar, Joseph
    COMPREHENSIVE PSYCHIATRY, 2024, 133
  • [34] Antipsychotic augmentation in the treatment of obsessive-compulsive disorder
    Thamby, Abel
    Jaisoorya, T. S.
    INDIAN JOURNAL OF PSYCHIATRY, 2019, 61 (07) : S51 - S57
  • [35] A 5-year prospective follow-up study of patients with obsessive-compulsive disorder treated with serotonin reuptake inhibitors
    Cherian, Anish V.
    Math, Suresh Bada
    Kandavel, Thennarasu
    Reddy, Y. C. Janardhan
    JOURNAL OF AFFECTIVE DISORDERS, 2014, 152 : 387 - 394
  • [36] Cognitive-Behavioral Therapy vs Risperidone for Augmenting Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder A Randomized Clinical Trial
    Simpson, Helen Blair
    Foa, Edna B.
    Liebowitz, Michael R.
    Huppert, Jonathan D.
    Cahill, Shawn
    Maher, Michael J.
    McLean, Carmen P.
    Bender, James, Jr.
    Marcus, Sue M.
    Williams, Monnica T.
    Weaver, Jamie
    Vermes, Donna
    Van Meter, Page E.
    Rodriguez, Carolyn I.
    Powers, Mark
    Pinto, Anthony
    Imms, Patricia
    Hahn, Chang-Gyu
    Campeas, Raphael
    JAMA PSYCHIATRY, 2013, 70 (11) : 1190 - 1198
  • [37] Double-Blind, Placebo-Controlled Trial of Topiramate Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder
    Berlin, Heather A.
    Koran, Lorrin M.
    Jenike, Michael A.
    Shapira, Nathan A.
    Chaplin, William
    Pallanti, Stefano
    Hollander, Eric
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (05) : 716 - 721
  • [38] N-Acetylcysteine Augmentation in Children and Adolescents Diagnosed With Treatment-Resistant Obsessive-Compulsive Disorder Case Series
    Yazici, Kemal Utku
    Percinel, Ipek
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (04) : 486 - 489
  • [39] Early Onset of Response With Selective Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder: A Meta-Analysis
    Issari, Yasmin
    Jakubovski, Ewgeni
    Bartley, Christine A.
    Pittenger, Christopher
    Bloch, Michael H.
    JOURNAL OF CLINICAL PSYCHIATRY, 2016, 77 (05) : E605 - E611
  • [40] Functional connectivity of the raphe nucleus as a predictor of the response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder
    Kim, Minah
    Kwak, Seoyeon
    Yoon, Youngwoo Bryan
    Kwak, Yoo Bin
    Kim, Taekwan
    Cho, Kang Ik K.
    Lee, Tae Young
    Kwon, Jun Soo
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (12) : 2073 - 2081
12345